AI-enabled, human-verified innovation for regulated industries
We operate as a virtual team combining AI systems with real-world expertise.
Our purpose: AI and human expertise working as one
We aim to accelerate innovation in consumer health and FMCG industries, combining the power of AI with the expertise of seasoned industry professionals. Our AI-powered platforms help you tackle the challenges of R&D, regulatory hurdles, and sustainability to create new, market-leading products faster and more efficiently.
- AI-powered Innovation: Bringing together AI's scalability with human expertise.
- Faster Market Entry: Reduce development cycles by combining AI and human collaboration.
- Confidentiality & Compliance: A human-verified platform that ensures regulatory compliance and data protection.
Meet the team
Dr. Lance Shaw FRSC
Managing Director & Chief Scientific Officer
Lance is a healthcare science leader with 35+ years of experience across R&D, product development, and manufacturing in global consumer health and pharma. A PhD-qualified expert in drug delivery and bioavailability, he has led major innovation portfolios for brands such as Voltaren, Allegra, and Mucosolvan—bringing over 100 products to market.
He combines deep scientific expertise with strategic vision, integrating AI-driven intelligence with human creativity to transform innovation pipelines.
Adriaan Melse, MSc
Senior Marketing Consultant
Adriaan is a mechanical engineer by training and a seasoned marketing executive with 25+ years of experience. He has led global brand strategy and innovation programmes, supporting the growth of large-scale consumer brands such as Pampers, and led global marketing and strategy on Voltaren as it grew to over $1 billion in global sales.
He brings deep expertise in brand strategy, innovation, and consumer behaviour, translating AI-generated insights into powerful, human-centric narratives that drive market impact.
Dr. Antje Howitz
Senior Regulatory Affairs Consultant
Antje is a regulatory affairs leader with 25+ years of experience across global pharma and consumer health. She has held senior roles at Sanofi and Boehringer Ingelheim and shaped regulatory strategies and innovation portfolios for major brands including Enterogermina, Buscopan, and NoSpa, and pioneered Rx-to-OTC switches and digital health innovation.
She brings deep expertise in regulatory strategy spanning a broad range of product classifications including drugs, medical devices, food supplements, and cosmetics, ensuring every concept is built on solid, forward-looking regulatory foundations.
Dr. Phil Berry
Senior Physician & Medical Affairs Consultant
Phil is a senior physician and medical affairs leader with over two decades of experience across global pharmaceutical and consumer health sectors. He has served as Global Medical Director, EU Qualified Person, and Head of Medical Affairs for leading OTC and pharmaceutical companies.
He brings deep expertise in clinical development, pharmacovigilance, and scientific governance, ensuring innovation is underpinned by medical integrity and patient safety.
Dr. Emma Rawlings
Senior Project Management Consultant
Emma has over 20 years of experience leading complex innovation programmes and transformation initiatives across global healthcare organisations. She has guided end-to-end delivery of innovation portfolios through major integrations, including the Pfizer/GSK joint venture and the Haleon demerger.
She brings deep expertise in programme execution and transformation, combining disciplined delivery with digital fluency to ensure projects run with strategic clarity, scientific rigour, and operational agility.
Adriana Paes Leme, LLM, MBA
Regulatory Affairs Expert
Adriana is a senior regulatory professional with 25+ years of experience in the pharmaceutical industry. She advises companies in highly regulated sectors on regulatory strategy and compliance. She has held leadership roles in multinational organisations, with extensive experience in regulatory agency interactions and in managing multicultural teams across jurisdictions.
She brings a multidisciplinary perspective grounded in degrees in Pharmacy and Law, an MBA, and a Master’s degree in Data Privacy and Cybersecurity. She helps ensure every GenovAI concept is built on solid, forward looking regulatory foundations.
Dr. Stefan Mueller
Science Expert
Stefan is a highly experienced scientific and medical affairs leader with 25+ years of expertise across pharmaceutical R&D, regulatory affairs, and early clinical development. A pharmacist with a PhD in pharmacokinetic/pharmacodynamic assessments from the University of Florida, he has held senior leadership roles at organisations including Uriach, Sanofi, and Mundipharma. He has extensive experience in innovation pipeline development, preclinical and clinical strategy, and leading cross functional teams across global markets.
He brings deep expertise in scientific evaluation, medical strategy, and product development, helping ensure GenovAI outputs are grounded in robust evidence and translated into credible, commercially relevant product concepts.
About Channel Health
Channel Health is a specialist innovation and strategy company operating at the intersection of human expertise and advanced AI in consumer health, pharma, and FMCG. We design and deploy AI-enabled, human-centric platforms that help organisations innovate faster, with greater confidence and stronger cross-functional alignment — without the cost and complexity of traditional agency-led models.
